CanPursue

Research

  • Search
  • Opportunities
  • Buyers
  • Suppliers
  • Contracts
  • Awards

Intelligence

  • OverviewAccount required
  • WatchlistsAccount required
  • PipelineAccount required
  • IntelligenceAccount required
Create free account

Sign in

⌘K
ENFR
Calcium Trisodium Pentetate (Ca-DTPA) ampoules | Department of National Defence (DND) · CanPursue
Opportunities
Fit is part of the trial and paid plans.Closes in 5 daysAdvance Contract Award Notice

Calcium Trisodium Pentetate (Ca-DTPA) ampoules

Department of National Defence (DND)W6369-27-A062Federal
Open official sourceAdd to pipeline
Published
Nov 10, 2026
Respond by
Nov 25, 2026, 14:00Closes in 5 days
Latest amendment
None

See how this opportunity fits your company

Create a free account and describe your company. With the trial, CanPursue checks every opportunity against it and explains the fit.

Create free account

Who won similar work

Create a free account to see past contracts like this one: who won and at what price.

Create free account

Description

NOTICE OF PROPOSED PROCUREMENT

The Department of National Defence (DND), through the Strategic Medical Countermeasures Program (SMCP) on behalf of the Canadian Forces Health Services Group (CF H Svcs Gp), has a requirement for the supply of Calcium Trisodium Pentetate (Ca-DTPA) ampoules for the treatment of Canadian Armed Forces (CAF) personnel who may have been exposed to radioactive contamination involving transuranic elements.

The Ca-DTPA product must consist of sterile Calcium Trisodium Pentetate solution for injection, containing approximately 1,000 mg to 1,055 mg of active ingredient in a 5 mL ampoule suitable for intravenous administration. The product is intended for use as a medical countermeasure to enhance the elimination of internally deposited radioactive transuranic elements, including plutonium, americium and curium, following confirmed or suspected radiological exposure. The product must meet all applicable regulatory, quality assurance, packaging, labelling and shelf-life requirements specified in the solicitation documents.

The initial requirement consists of the supply of 250 Ca-DTPA ampoules for delivery no later than 1 March 2027. The resulting contract is anticipated to be valid from contract award date to 31 March 2031 and includes additional scheduled deliveries of 250 ampoules in Fiscal Year 2027-2028 and 250 ampoules in Fiscal Year 2028-2029. The contract will also include an option for up to an additional 500 ampoules exercisable during the contract period.

This procurement will be conducted through an Advance Contract Award Notice (ACAN). The Government of Canada has identified Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG as the only supplier currently known to satisfy the operational, clinical and technical requirements associated with this requirement. Suppliers that consider themselves fully qualified and capable of meeting the complete requirement may submit a Statement of Capabilities during the posting period.

The Crown retains the rights to negotiate with suppliers on any procurement.

Documents may be submitted in either official language of Canada.

Barring any applicable trade agreement exceptions or other legal restrictions, eligible suppliers may participate in this solicitation process.

NOTE TO SUPPLIERS: Procurement Assistance Canada offers seminars to businesses interested in learning how to sell goods and services to the Government of Canada. These seminars are provided free of charge.

Procurement

Procurement type
Advance Contract Award Notice
Procurement method
Advance contract award notice
Selection criteria
Not applicable
Category
Goods
Jurisdiction
Federal
Region of delivery
Canada
Region of opportunity
Canada
Expected contract period
Dec 11, 2026 to Mar 31, 2029

Not stated in the notice: end user

Requirements and qualifications

Supply arrangement
Not stated in the public notice
Security requirement
Not stated in the public notice
Trade agreements
Canadian Free Trade Agreement (CFTA)
Limited tendering reason
—

Classification

GSIN
—
UNSPSC
51000000 Drugs and Pharmaceutical Products

Amendments

No amendments observed.

Documents

  • w6369-27-a062_ca-dtpa_acan_eng.pdf

Contact

Eduardo Videsluiseduardo.videslozano@forces.gc.ca(873) 469-7365

Related

More from this buyer

  • Multiple Victoria-Class Spares: Packing Retainer, Gaskets, Packing Assembly, Valves, Starter, Motor; Interval Timer, Expansion Joint, Pipe, O-RingNov 20
  • Canopy and Riser AssemblyNov 20
  • E-Waste Destruction and Recycling ServicesNov 20
  • Communications Management and Monitoring EquipmentNov 20
  • Circuit Card AssemblyNov 20

Linked contracts

No related records observed.

Source

Open official source

Verify the notice and download the full solicitation on the official page.

Source
CanadaBuys
Solicitation
W6369-27-A062
Reference number
cb-141-88756202
Observed
Nov 19, 2026

The amount, value range and contract duration shown on some CanadaBuys pages are not in the open data, so CanPursue does not show them.

Never miss an amendment

Track this opportunity in your pipeline and watchlists with a free account.

Create free account